shu88

ARWR Possible Entry Point

Long
shu88 Updated   
NASDAQ:ARWR   Arrowhead Pharmaceuticals, Inc.
I have noticed a support at the $31.50 to $32.00 range. Assessing the risk reward ratio any price below $32 would be a good buy. Also, from the Stoch RSI we can see that the stock is currently under sold so perhaps we can expect a reversal.
Comment:
oversold*
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.